Affymetrix's Q3 Revenues Down 5 Percent on Service Business Decline | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A $5 million decline in service revenues was one of the reasons for a 5 percent drop in total revenues for Affymetrix during its third quarter, the company reported Wednesday after the close of the market.

For the three months ended Sept. 30, the Santa Clara, Calif.-based microarray firm reported total revenues of $74 million, down from $78.2 million a year ago, but still above analyst estimates of $73.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: certain genes repressed during memory formation, analysis of genomes from single neurons, and more.

NASA plans to test whether DNA sequencing studies can be conducted in microgravity.

Congress passes a continuing resolution to keep the US federal government funded through mid-December.

The Human Genome Project was launched 25 years ago, and at Nature, Francis Collins, James Watson, and Eric Green look back at the lessons learned.